Olga A. Kofeynikova

Olga A. Kofeynikova

Auto-generated profile, based on publicly available information

Olga A. Kofeynikova

Almazov National Medical Research Centre

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2022 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
DAD. Yu. Alekseeva
D. Yu. Alekseeva
OKO. А. Kofeynikova
O. А. Kofeynikova
DMDamir Marapov
Damir Marapov
EVElena Vasichkina
Elena Vasichkina
Arrhythmogenic cardiomyopathy (ACM) is a rare genetic disease characterized by the development of life-threatening ventricular arrhythmias and impaired ventricular systolic function due to fibrofatty infiltration of the myocardium. Currently, the Task Force 2010 criteria and the Padua criteria are proposed for the diagnosis of this disease. However, despite the multiparametric approach, there are certain limitations of the presented algorithms for disease establishment, especially in children. Carrying out such high-tech diagnostic methods as endomyocardial biopsy and magnetic resonance imaging is extremely difficult in the pediatric population. In this regard, the study and application of electrocardiography becomes extremely relevant in children. In addition, there are no data on the features of ventricular arrhythmias in ACM in the pediatric population. In this systematic review with meta-analysis, we studied the features of ventricular arrhythmias and electrocardiographic parameters in various ACM types.

22 October 2022 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
DAD. Yu. Alekseeva
D. Yu. Alekseeva
OKO. A. Kofeynikova
O. A. Kofeynikova
DMDamir Marapov
Damir Marapov
EVElena Vasichkina
Elena Vasichkina
Arrhythmogenic cardiomyopathy (ACM) is a progressive disease with a high risk of sudden cardiac death (SCD), which is very rare in the pediatric population. Aim. To study the clinical course, outcomes and prognosis in various ACM phenotypes in pediatric patients.Material and methods. During the initial selection, 144 publications were found in the PubMed database. From the initially identified results, an analysis of 7 works was carried out.Results. Positive family history for ACM was revealed in 90% of cases. Every second patient had symptoms of the disease (49,2% (95% confidence interval (CI): 19,3-79,1)). Frequent clinical manifestations of ACM were palpitations, heart failure symptoms, and syncope. The incidence of SCD and sudden cardiac arrest was 7,1% (95% CI: 1,7-12,4) and 5,1% (95% CI: 1,5-8,7), respectively. Implantation of an implantable-cardioverter defibrillator was performed in 40% of cases. Conclusion. We did not reveal any specificity of clinical signs depending on ACM phenotype. However, an earlier onset and an unfavorable course are characteristic of non-classical ACM types. ACM is characterized by a high risk of SCD, so it is extremely important to make a timely diagnosis.

27 June 2023 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
OKO. A. Kofeynikova
O. A. Kofeynikova
DAD. Yu. Alekseeva
D. Yu. Alekseeva
SFS. G. Fetisova
S. G. Fetisova
EYE. V. Yakovleva
E. V. Yakovleva
OPO. L. Peregudina
O. L. Peregudina
EVElena Vasichkina
Elena Vasichkina
This article describes a rare clinical manifestation of arrhythmogenic cardiomyopathy in a 13-year-old boy - the “hot phase”, characterized by severe chest pain and a significant increase on a level of troponin I. The clinical case demonstrates the difficulties of the differential diagnosis of this disease and an importance of an integrated approach to examination of the patient, including cardiac magnetic resonance imaging and genetic testing.

13 June 2025 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
OKO. A. Kofeynikova
O. A. Kofeynikova
KCK. A. Chueva
K. A. Chueva
AKAnna Kostareva
Anna Kostareva
SFS. G. Fetisova
S. G. Fetisova
DLD. S. Lebedev
D. S. Lebedev
EVElena Vasichkina
Elena Vasichkina
Aim. To investigate clinical manifestations, phenotypic variants, genetic features, and outcomes in children with arrhythmogenic cardiomyopathy (ACM).Methods. The study group consisted of 24 patients (< 18 years of age) with ACM, who were under observation from 2011 to 2024. The median age at ACM diagnosis was 13 years [12-15]. The following data were analyzed: complaints and medical history, laboratory parameters (biochemical markers of inflammation and serum myocardial damage mar­ kers, NT-proBNP levels), electrocardiogram, Holter monitoring, echocardiography results, cardiac magnetic resonance imaging, selective coronary angiography, histological and molecular genetic studies. The median follow-up duration for ACM patients was 27 months [16.5-38].Results. All patients were unrelated probands. All children presented with asymptomatic ventricular arrhythmias (VA) as the initial manifestation of the disease, 23 (95.8%) patients had complaints: palpitations in 21 (87.5%) children, syncope in 14 (58.3%) children, heart failure symptoms in 12 (50.0%), and isolated chest pain in 4 (16.7%) patients. 5 (20.8%) children had a “hot” phase. Analysis of arrhythmic data revealed several features of ACM in childhood: VAs were polymorphic, daily VA density was less than 20% at the time of diagnosis, presence of late ventricular potentials in most patients, and several criteria from the «repolarization abnormalities» group had low informativeness. During follow-up, 9 (37.5%) children had the right-dominant ACM, 7 (29.9%) had ACM with left ventricle involvement, and 8 (33.3%) had biventricular form. Desmosomal mutations were found in 16 children (66.7%), non-desmosomal gene variants in 8 patients (33.3%).Conclusion. It has been shown that ACM can manifest at an early age and is associated with the development of arrhythmic events and/or severe heart failure. Increasing awareness among physicians about the early onset of ACM is crucial for timely treatment of heart failure, prevention of sudden cardiac death, and family screening.

13 January 2024 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
KCK. A. Chueva
K. A. Chueva
RTR. B. Tatarskiy
R. B. Tatarskiy
DLDlebedev Lebedev
Dlebedev Lebedev
OKO. A. Kofeynikova
O. A. Kofeynikova
TKT. S. Kovalchuk
T. S. Kovalchuk
EVElena Vasichkina
Elena Vasichkina
Ventricular arrhythmias (VAs) in children are generally idiopathic and have a benign course. Catheter ablation (CA) is increasingly becoming a first-line treatment option in children with idiopathic VAs. Acute ablation success reaches 100% procedures and long-term – 87%. Predictors of outcomes of CA in pediatric patients with idiopathic VAs have not been fully investigated.Aim: To identify predictors of long-term unsuccessful outcomes of CA in pediatric idiopathic VAs.Material and Methods. This retrospective study included 164 children aged 7 to 17 years with idiopathic VAs, who underwent CA from 2011 until 2023 in Almazov National Medical Research Centre. Efficiency was assessed in acute period and 6 months after CA.Results. In this study the acute success was 92% and long-term success was 88,4%. In multivariable models, multifocal VAs (odds ratio: 8,814; 95% CI: 1,943–39,981; p = 0,005), effectiveness of antiarrhythmic therapy (odds ratio: 16,522; 95%CI: 1,959–139,374; p = 0,010) and noninducibility of VAs during procedure (odds ratio: 9,369; 95% CI: 1,400–62,684; 0,021), become predictors of long-term unsuccessful outcomes of CA in pediatric idiopathic VAs.Conclusion. In our study there were identified independent predictors of long-term noneffective CA in children with idiopathic VAs, such as multifocal VAs, effectiveness of antiarrhythmic therapy, and noninducibility of VAs CA. In patients with presence of two or more ventricular foci and the effectivness of antiarrhythmic therapy, prolongate drug therapy may be more preferable.

28 December 2023 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
OKOlga A. Kofeynikova
Olga A. Kofeynikova
DADarya Yu. Alexeeva
Darya Yu. Alexeeva
ECEvgeniya V. Characterova
Evgeniya V. Characterova
AKAnna Kostareva
Anna Kostareva
EVElena Vasichkina
Elena Vasichkina
ЕХЕ. В. Характерова
Е. В. Характерова
This article describes the onset of arrhythmogenic cardiomyopathy, left-dominant form, in a pediatric patient that was initially regarded as dilated cardiomyopathy. This clinical case shows issues of the disease differential diagnosis and the need of complex approach to the patient’s examination including heart magnetic resonance imaging and molecular and genetic testing.